Digital Mindfulness for Young Adults With Type 1 Diabetes

Launched by YALE UNIVERSITY · Jul 3, 2025

Keywords

ClinConnect Summary

This study is looking at how a mindfulness app called Calm Health might help young adults with type 1 diabetes or similar types of diabetes that require insulin. Mindfulness means paying attention to your thoughts and feelings right now, without judging yourself. The app will guide participants through mindfulness exercises and give personalized feedback about how their mindfulness relates to their blood sugar levels, stress, and sleep.

To join, you need to be between 18 and 30 years old, have had type 1 diabetes or a similar condition for at least a year, and use a continuous glucose monitor (a device that tracks blood sugar) as part of your regular care. You also need to be a patient at Yale New Haven Children’s Hospital or Yale New Haven Hospital and able to use a smartphone. During the study, participants will follow the mindfulness program and share information about their health and experiences. The study is not yet recruiting, and people who already practice mindfulness regularly or have certain mental health issues may not be eligible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Receiving diabetes care at Yale New Haven Children's Hospital or Yale New Haven Hospital.
• • 2. Sign and date informed consent form we will provide
• • 3. Willingness to complete procedures and availability for duration of the study
• • 4. Aged 18-30 years
• • 5. Diagnosed with type 1 diabetes (T1D) or other absolute insulin deficiency diabetes (latent autoimmune diabetes of adulthood, diabetes secondary to pancreatitis) for at least 1 year.
• • 6. User of a continuous glucose monitor (CGM) in your routine clinical care for at least the past 2 weeks.
• • 7. Able to use a smartphone.
• • 8. Able to read and write English.
• Exclusion Criteria:
• • 1. Current meditation or mindfulness practice meeting or exceeding the study's recommended schedule
• • 2. Current severe untreated psychiatric illness (e.g., bipolar disorder, schizophrenia, major depression, panic disorder, borderline personality disorder, organic mood or mental disorders) or active suicidal ideation
• • 3. New or unstable psychopharmaceutical treatment in past 2 months.
• • 4. Current or planned pregnancy during study period.